STAAR Surgical Co (STAA), established in 1982, is a publicly traded company headquartered in Monrovia, California. This world-renowned firm, listed on the NASDAQ, specializes in the development, manufacturing, and distribution of implantable lenses for the eye and delivery systems used in refractive surgery.
The company primarily serves the larger ophthalmic industry and is celebrated as an industry pioneer. STAAR Surgical Co is known for its leading-edge innovations in visual optics, working on the forefront of introducing significant improvements that benefit patients and physicians around the world. Its trailblazing innovations include Lasik eye surgery and the implantation of silicone contact lenses.
The most well-known product of STAAR Surgical is the implantable Collamer lens, or ICL, a category it leads globally. This implantable lens is designed to treat myopia or nearsightedness, a medical issue affecting millions across the globe. These lenses, which are implanted in a quick and minimally invasive surgery, offer patients a potentially life-changing alternative to glasses and traditional contact lenses.
Remarkably, the company has sold more than 1 million ICLs since its launch. It continues to invest heavily in research and development to introduce new technologies that could revolutionize vision correction and eye care.
Internationally, STAA has a broad footprint with offices in Switzerland and Japan, and its products are available to medical professionals in over 75 countries. Their global presence proves their commitment to making the latest eye care solutions accessible to people worldwide and affirms their position as a global leader in the ophthalmic sector.
STAAR Surgical Co follows a growth strategy focused on increasing brand awareness, expanding its product portfolio, and broadening its global distribution. Given the increasing demand for advanced eye care solutions, Staar Surgical is well-positioned to grow significantly in the future.
The company, under the leadership of Caren Mason, who has been its Chief Executive Officer since 2015, is committed to providing safe, intuitive, and reliable eye care solutions. As an active corporate citizen, STAA also carries a commitment to various global philanthropic efforts offering vision correction surgery to people who otherwise could not afford it.
In all, STAAR Surgical Co is a true industry leader, pushing boundaries in the eye care sector, and carrying a firm commitment to improving patients' vision quality and life.